Literature DB >> 7561818

Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders.

J M Jerrell1, M S Ridgely.   

Abstract

This study examines the rationale for and relative effectiveness of three intervention models for treating people with severe mental illness and substance abuse disorders: Twelve Step recovery, behavioral skills training, and intensive case management. Using clinical trial methods, 132 dually diagnosed clients were assigned to three service approaches. Changes in client psychosocial outcomes, and psychiatric and substance abuse symptomatology were tracked over a 24-month period. Differential effectiveness was evident, with clients in the behavioral skills group demonstrating the most positive and significant differences in psychosocial functioning and symptomatology, compared with the Twelve Step recovery approach. However, the case management intervention also resulted in several positive and important differences compared with the Twelve Step recovery approach. We also found significant changes over time, not only at 6 months but increasingly positive changes in psychosocial functioning at 12 and 18 months as well. These results underscore the need for clinical trials to further examine the relative cost effectiveness of treatment approaches for dually disordered clients and to incorporate means of assessing subgroup differences so that the interventions being tested can be further refined and targeted to a broad set of needs among the dually diagnosed.

Entities:  

Mesh:

Year:  1995        PMID: 7561818     DOI: 10.1097/00005053-199509000-00002

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  26 in total

Review 1.  Managing comorbid schizophrenia and substance abuse.

Authors:  R E Drake; K T Mueser
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 2.  Psychosocial treatments for schizophrenia.

Authors:  A S Bellack; S A Brown
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 3.  Intensive case management for severe mental illness.

Authors:  Marina Dieterich; Claire B Irving; Bert Park; Max Marshall
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

4.  Further validation of the Psycho-Social Well-Being Scale (PSWS) with community clients.

Authors:  Thomas O'Hare; Margaret V Sherrer; Hilary Smith Connery; Jay Thornton; Annamaria LaButti; Kelly Emrick
Journal:  Community Ment Health J       Date:  2003-04

5.  Predictors of retention in dual-focus self-help groups.

Authors:  Alexandre B Laudet; Stephen Magura; Charles M Cleland; Howard S Vogel; Edward L Knight
Journal:  Community Ment Health J       Date:  2003-08

6.  Evidence-based practices in community mental health: outcome evaluation.

Authors:  Kirstin Painter
Journal:  J Behav Health Serv Res       Date:  2012-10       Impact factor: 1.505

7.  A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders.

Authors:  Kim T Mueser; Shirley M Glynn; Corrine Cather; Haiyi Xie; Roberto Zarate; Lindy Fox Smith; Robin E Clark; Jennifer D Gottlieb; Rosemarie Wolfe; James Feldman
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

Review 8.  Behavioral therapies for co-occurring substance use and mood disorders.

Authors:  Kathleen M Carroll
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

9.  Unmet need for community-based mental health and substance use treatment among rural adolescents.

Authors:  Rachel L Anderson; Josephine Gittler
Journal:  Community Ment Health J       Date:  2005-02

Review 10.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.